BIOMAT Database Logo BIOMAT Database Logo

Pharmacology of oxytocin and vasopressin receptors in the central and peripheral nervous system. 1992

C Barberis, and S Audigier, and T Durroux, and J Elands, and A Schmidt, and S Jard
Centre CNRS-INSERM de Pharmacologie-Endocrinologie, Montpellier, France.

UI MeSH Term Description Entries
D010121 Oxytocin A nonapeptide hormone released from the neurohypophysis (PITUITARY GLAND, POSTERIOR). It differs from VASOPRESSIN by two amino acids at residues 3 and 8. Oxytocin acts on SMOOTH MUSCLE CELLS, such as causing UTERINE CONTRACTIONS and MILK EJECTION. Ocytocin,Pitocin,Syntocinon
D010525 Peripheral Nerves The nerves outside of the brain and spinal cord, including the autonomic, cranial, and spinal nerves. Peripheral nerves contain non-neuronal cells and connective tissue as well as axons. The connective tissue layers include, from the outside to the inside, the epineurium, the perineurium, and the endoneurium. Endoneurium,Epineurium,Perineurium,Endoneuriums,Epineuriums,Nerve, Peripheral,Nerves, Peripheral,Perineuriums,Peripheral Nerve
D011945 Receptors, Angiotensin Cell surface proteins that bind ANGIOTENSINS and trigger intracellular changes influencing the behavior of cells. Angiotensin Receptor,Angiotensin Receptors,Angiotensin II Receptor,Angiotensin III Receptor,Receptor, Angiotensin II,Receptor, Angiotensin III,Receptor, Angiotensin
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D017483 Receptors, Vasopressin Specific molecular sites or proteins on or in cells to which VASOPRESSINS bind or interact in order to modify the function of the cells. Two types of vasopressin receptor exist, the V1 receptor in the vascular smooth muscle and the V2 receptor in the kidneys. The V1 receptor can be subdivided into V1a and V1b (formerly V3) receptors. Antidiuretic Hormone Receptors,Receptors, V1,Receptors, V2,V1 Receptors,V2 Receptors,Vasopressin Receptors,8-Arg-Vasopressin Receptor,Antidiuretic Hormone Receptor,Antidiuretic Hormone Receptor 1a,Antidiuretic Hormone Receptor 1b,Arginine Vasopressin Receptor,Argipressin Receptor,Argipressin Receptors,Receptor, Arginine(8)-Vasopressin,Renal-Type Arginine Vasopressin Receptor,V1 Receptor,V1a Vasopressin Receptor,V1b Vasopressin Receptor,V2 Receptor,Vascular-Hepatic Type Arginine Vasopressin Receptor,Vasopressin Receptor,Vasopressin Receptor 1,Vasopressin Type 1A Receptor,Vasopressin V1a Receptor,Vasopressin V1b Receptor,Vasopressin V2 Receptor,Vasopressin V3 Receptor,8 Arg Vasopressin Receptor,Hormone Receptor, Antidiuretic,Hormone Receptors, Antidiuretic,Receptor, Antidiuretic Hormone,Receptor, Arginine Vasopressin,Receptor, Argipressin,Receptor, V1,Receptor, V2,Receptor, Vasopressin,Receptor, Vasopressin V1b,Receptor, Vasopressin V3,Receptors, Antidiuretic Hormone,Receptors, Argipressin,Renal Type Arginine Vasopressin Receptor,V1b Receptor, Vasopressin,Vascular Hepatic Type Arginine Vasopressin Receptor,Vasopressin Receptor, V1b
D057911 Angiotensin Receptor Antagonists Agents that antagonize ANGIOTENSIN RECEPTORS. Many drugs in this class specifically target the ANGIOTENSIN TYPE 1 RECEPTOR. Angiotensin II Receptor Antagonist,Angiotensin II Receptor Blocker,Angiotensin Receptor Antagonist,Angiotensin Receptor Blocker,Angiotensin II Receptor Antagonists,Angiotensin II Receptor Blockers,Angiotensin Receptor Blockers,Antagonist, Angiotensin Receptor,Antagonists, Angiotensin Receptor,Blocker, Angiotensin Receptor,Receptor Antagonist, Angiotensin,Receptor Antagonists, Angiotensin,Receptor Blocker, Angiotensin,Receptor Blockers, Angiotensin
D018045 Receptors, Oxytocin Cell surface proteins that bind oxytocin with high affinity and trigger intracellular changes which influence the behavior of cells. Oxytocin receptors in the uterus and the mammary glands mediate the hormone's stimulation of contraction and milk ejection. The presence of oxytocin and oxytocin receptors in neurons of the brain probably reflects an additional role as a neurotransmitter. Oxytocin Receptors,Oxytocin Receptor,Receptor, Oxytocin

Related Publications

C Barberis, and S Audigier, and T Durroux, and J Elands, and A Schmidt, and S Jard
Vasopressin and oxytocin receptors in the central nervous system.
January 1996, Critical reviews in neurobiology,
C Barberis, and S Audigier, and T Durroux, and J Elands, and A Schmidt, and S Jard
Pharmacology and biochemistry of dopamine receptors in the central nervous system and peripheral tissue.
January 1986, Journal of neural transmission. Supplementum,
C Barberis, and S Audigier, and T Durroux, and J Elands, and A Schmidt, and S Jard
[The role of oxytocin and vasopressin in central nervous system activity and mental disorders].
January 2012, Psychiatria polska,
C Barberis, and S Audigier, and T Durroux, and J Elands, and A Schmidt, and S Jard
The analgesic effects of oxytocin in the peripheral and central nervous system.
February 2017, Neurochemistry international,
C Barberis, and S Audigier, and T Durroux, and J Elands, and A Schmidt, and S Jard
Oxytocin receptors in the central nervous system. Distribution, development, and species differences.
June 1992, Annals of the New York Academy of Sciences,
C Barberis, and S Audigier, and T Durroux, and J Elands, and A Schmidt, and S Jard
[Oxytocin and the central nervous system].
June 2007, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,
C Barberis, and S Audigier, and T Durroux, and J Elands, and A Schmidt, and S Jard
Receptors for gammaglobulin in the central and peripheral nervous system.
November 1994, Journal of neurology, neurosurgery, and psychiatry,
C Barberis, and S Audigier, and T Durroux, and J Elands, and A Schmidt, and S Jard
Distribution of cannabinoid receptors in the central and peripheral nervous system.
January 2005, Handbook of experimental pharmacology,
C Barberis, and S Audigier, and T Durroux, and J Elands, and A Schmidt, and S Jard
Pharmacology and the central nervous system.
October 1965, Developmental medicine and child neurology,
C Barberis, and S Audigier, and T Durroux, and J Elands, and A Schmidt, and S Jard
Experimental approaches for the study of oxytocin and vasopressin gene expression in the central nervous system.
January 2008, Progress in brain research,
Copied contents to your clipboard!